Vitellogenin polypeptide levels in one susceptible and one cadmium-resistant strain of Oncopeltus fasciatus (Heteroptera: Lygaeidae), and its role in cadmium resistance.
The heavy metal Cd has recently been shown to have endocrine disrupting activity in different vertebrate species. In the insect Oncopeltus fasciatus, Cd exposure delays ovarian maturation and inhibits vitellogenesis, probably through a reduction in vitellogenin (Vg) polypeptide synthesis. An O. fasciatus strain was selected in the laboratory for Cd resistance with gradually increasing Cd concentrations for 50 generations. Cd-selected (OCdR) insects were 2.7-2.3 times more resistant to chronic exposure to Cd than susceptible (OS) insects. OCdR females showed increased (up to 90%) Vg polypeptide levels in hemolymph. Vg polypeptide synthesis was equally decreased in OCdR and OS females after acute Cd exposure, indicating that resistance in the OCdR strain was not due to a reduced sensitivity of the target of Cd. Vg polypeptide concentrations and ovarian maturation in acutely exposed OCdR females, however, were equal to those of control OS females. OCdR females chronically exposed to Cd showed a 30% decrease in Vg polypeptide concentrations, relative to control OS females. It is concluded that increased Vg polypeptide levels play an important role in resistance to the toxic effects of Cd on reproduction in the OCdR strain, and that this novel Cd resistance mechanism has the potential to evolve in vertebrate species in which Cd inhibits Vg synthesis by disruption of the endocrine system.
Cervera
Amelia
A
Departamento de Biología Funcional y Antropología Física, Universitat de València, Dr. Moliner 50, 46100 Burjassot, Valencia, Spain. amelia.cervera@uv.es
Maymó
Ana Cristina
AC
Martínez-Pardo
Rafael
R
Garcerá
María Dolores
MD
D000818:Animals; D002104:Cadmium / Q000633:toxicity*; D004591:Electrophoresis, Polyacrylamide Gel; D052244:Endocrine Disruptors / Q000633:toxicity*; D005260:Female; D006458:Hemolymph / Q000737:chemistry; D020062:Heteroptera / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism* / Q000502:physiology; D008297:Male; D018675:Toxicity Tests; D014818:Vitellogenesis / Q000502:physiology; D014819:Vitellogenins / Q000378:metabolism*
D052244:Endocrine Disruptors; D014819:Vitellogenins; D002104:Cadmium